Summit Therapeutics (SMMT) Earnings Date & Reports

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SMMT is expected to report earnings to rise 33.57% to -9 cents per share on August 06

Summit Therapeutics SMMT Stock Earnings Reports

Q2'25

Est.

$-0.09

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.03

The last earnings report on May 01 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 2.53M shares outstanding, the current market capitalization sits at 17.79B.

View a ticker or compare two or three

Compare

SMMT